Absci to Participate in Upcoming Investor Conferences

Absci (Nasdaq: ABSI) announced participation in two investor conferences in New York.

Rhea-AI Summary

Absci (Nasdaq: ABSI) announced participation in two investor conferences in New York. The company will host a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, and at the Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026. Live and archived webcasts will be available on Absci’s investor relations website.

Argus Sep 1 session 1 alert

-2.21% close to close 3.5x rel. volume Open Argus

Details

News Market Reaction – ABSI

$1.49B Market Cap

On Sep 1, the day this news came out, ABSI closed 2.21% below the previous close. Relative volume reached 3.5x the daily average during tracking.

Data tracked by StockTitan Argus for the Sep 1 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, Wash. and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences:

• H.C. Wainwright 28^th Annual Global Investment Conference (New York, NY)
  

Fireside chat on Tuesday, September 15^th at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time

• Morgan Stanley 24^th Annual Global Healthcare Conference (New York, NY)
  

Fireside chat on Wednesday, September 16^th at 7:45 a.m. Eastern Time / 4:45 a.m. Pacific Time

Interested parties may access live and archived webcasts of the fireside chat sessions on the company’s investor relations website at: investors.absci.com.

About Absci

Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation™ platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci’s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201™, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for pattern hair loss. ABS-201 is also being investigated as a potential “best-in-class” therapeutic for endometriosis, a condition with significant unmet medical need and market potential. Absci is headquartered in Vancouver, WA, with AI Research Labs in New York City and Serbia, and an Innovation Center in Switzerland. Learn more at www.absci.com or follow us on LinkedIn (@absci), X (@Abscibio) and YouTube.

Absci® standard character mark, ABS-201™, and Integrated Drug Creation™ are trademarks and registered trademarks of Absci Corporation.

Investor Contact
Alexander D.H. Khan
Corporate Vice President
Head of Investor Relations
investors@absci.com 

Media Contact
press@absci.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Absci (ABSI) present at the H.C. Wainwright 28th Annual Global Investment Conference in 2026?

Absci will hold a fireside chat on Tuesday, September 15, 2026, at 3:30 p.m. Eastern Time. According to Absci, interested investors can access the live webcast and replay through the company’s investor relations website at investors.absci.com for later viewing.

What time is Absci's (ABSI) session at the Morgan Stanley 24th Annual Global Healthcare Conference 2026?

Absci’s fireside chat is scheduled for Wednesday, September 16, 2026, at 7:45 a.m. Eastern Time. According to Absci, this event will also be webcast live, with an archived version accessible afterward via the company’s investor relations website for investors.

How can investors access the Absci (ABSI) webcasts for the September 2026 investor conferences?

Investors can access live and archived Absci webcasts at investors.absci.com. According to Absci, both the H.C. Wainwright and Morgan Stanley fireside chat sessions will be streamed there, allowing real-time listening or on-demand replay for those unable to attend live.

Are replays available for Absci’s (ABSI) September 2026 investor conference fireside chats?

Yes, replays of Absci’s September 2026 fireside chats will be available as archived webcasts. According to Absci, both the H.C. Wainwright and Morgan Stanley sessions can be replayed through the company’s investor relations website after the live events conclude.

What type of company is Absci (Nasdaq: ABSI) that is presenting at these 2026 conferences?

Absci is a clinical-stage biopharmaceutical company developing therapeutics using generative AI. According to Absci, its participation in the 2026 H.C. Wainwright and Morgan Stanley conferences offers investors insight into its pipeline, technology platform, and overall corporate strategy.